Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Helen of Troy

This article was originally published in The Rose Sheet

Executive Summary

Increased focus on wholesale business within personal products segment has "stabilized or at least created a core business in Tactica and left us with less volatility," Senior VP, Chief Financial Officer Russell Gibson tells analysts Oct. 10. Wholesale advances in Tactica, which markets Epil-Stop and IGIA brands, were offset by significant drop in direct response sales, leading to 35% decline in overall division revenue in fiscal second quarter ended Aug. 31, exec notes. Drop was "almost entirely attributable" to reduced sales of Epil-Stop in direct response channel, Gibson says. Firm's consolidated sales fell 1.4% to $111 mil. in Q2, while net income jumped 22% to $8.9 mil. due to cost control initiatives. Full "ramp up" of Clairol brands to be acquired through agreement with P&G will take at least six months, company states. Completion of deal, which covers six hair and skin care brands, is expected within 90 days (1"The Rose Sheet" Sept. 30, 2002, p. 3)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS010667

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel